Hyderabad/Ahmedabad, July 24, 2025:
Dr. Reddy’s Laboratories Ltd., a leading global pharmaceutical company committed to providing affordable and innovative medicines, is pleased to announce its selection of Optiblack as its official analytics partner. This strategic collaboration marks a significant milestone in Dr. Reddy’s data-driven transformation journey, further unlocking revenue potential through advanced data analytics.
Founded in 1984 and headquartered in Hyderabad, Dr. Reddy’s Laboratories has established itself as a trailblazer in the pharmaceutical sector. With a robust presence across over 190 medications and 60 active pharmaceutical ingredients spanning critical therapeutics such as oncology, cardiovascular, diabetes, pain management, and more, the company is focused on innovative approaches to serve patients worldwide. Dr. Reddy’s has consistently expanded into global markets, notably the USA, Russia, Europe, and CIS countries, and is recognized for its commitment to good health and patient-centric solutions.
Recognizing the transformative power of data, Dr. Reddy’s Laboratories made the strategic decision to partner with Optiblack, a rapidly rising leader in analytics consulting, to drive actionable insights that will fuel revenue and operational efficiency. Optiblack’s expertise is set to empower Dr. Reddy’s with the ability to translate complex healthcare data into meaningful outcomes, guiding strategic business decisions and enabling uncovering of new growth opportunities.
Optiblack, based in Ahmedabad, has quickly become a preferred analytics partner for forward-thinking enterprises across Asia Pacific. The firm is celebrated for its deep product consulting acumen, technical prowess, and a portfolio that includes major SaaS implementations and partnerships with industry leaders. Optiblack received the "Solution Partner of the Year for APAC" award by Mixpanel, in recognition of its exceptional ability to help companies implement and extract value from advanced data platforms.
Through its customer-centric approach, Optiblack specializes in:
Designing and executing data analytics strategies tailored for operational and revenue outcomes.
Implementing best-in-class analytics solutions that enable real-time decision making.
Providing post-implementation training, support, and ongoing optimization for continuous improvement.
Assisting product and business leaders in transforming data insights into measurable financial impact.
With experience spanning over 40 companies and proven outcomes of driving millions in revenue impact, Optiblack is uniquely positioned to assist Dr. Reddy’s in harnessing its vast data assets.
Vishal Rewari, CEO of Optiblack, remarked:
“We are honored to become the analytics partner for Dr. Reddy’s Laboratories. By integrating advanced analytics into their digital ecosystem, we look forward to elevating data-driven decision making and unlocking new avenues for sustained revenue growth.”
The collaboration between Dr. Reddy’s Laboratories and Optiblack signifies a shared vision to revolutionize digital health through the power of analytics. The partnership will focus on deploying state-of-the-art analytics frameworks, upskilling teams, and embedding a culture of data throughout the organization. Together, both companies strive to serve better patient outcomes and set a benchmark for analytics-driven impact in the pharmaceutical industry.